AMRX · Forms 3, 4, 5

Insider trades at Amneal Pharmaceuticals, Inc.

3 insiders sold $7.2M of Amneal Pharmaceuticals, Inc. stock on the open market in the last 90 days.

Every Form 3, 4 and 5 filed for Amneal Pharmaceuticals, Inc. (AMRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
J Kevin BuchiDirectorGift20,445Form 4
J Kevin BuchiDirectorOption exercise20,445$14.45$295KForm 4
Andrew S BoyerExecutive Vice PresidentGift80,000Form 4
Andrew S BoyerExecutive Vice PresidentGift152,426Form 4
John KielyDirectorSell50,000$17.64$882KForm 4
John KielyDirectorGift10,000Form 4
Nikita ShahExecutive Vice PresidentSell146,403$17.51$2.6MForm 4
Jason B. DalyEVP, Chief Legal OfficerSell210,000$17.40$3.7MForm 4
Jason B. DalyEVP, Chief Legal OfficerSell6,613$17.70$117KForm 4
J Kevin BuchiDirectorOption exercise168,573$17.18$2.9MForm 4
Tushar Bhikhubhai Patel10% ownerAward12,763,469Form 4
Chintu PatelCo-CEOAward6,381,734Form 4
Gautam PatelDirectorAward283,632Form 4
Chirag K. PatelPresident & Co-CEOAward6,381,734Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.